| David Lawrence Mental Health Center, Inc | |
|
6075 Bathey Ln Naples FL 34116-7536 | |
| (239) 455-8500 | |
| (239) 455-6561 |
| Full Name | David Lawrence Mental Health Center, Inc |
|---|---|
| Speciality | Community/Behavioral Health |
| Location | 6075 Bathey Ln, Naples, Florida |
| Authorized Official Name and Position | Scott Burgess (CEO) |
| Authorized Official Contact | 2394558500 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| David Lawrence Mental Health Center, Inc 6075 Bathey Ln Naples FL 34116-7536 Ph: (239) 455-8500 | David Lawrence Mental Health Center, Inc 6075 Bathey Ln Naples FL 34116-7536 Ph: (239) 455-8500 |
| NPI Number | 1801891940 |
|---|---|
| Provider Enumeration Date | 06/16/2005 |
| Last Update Date | 03/18/2020 |
| Certification Date | 03/18/2020 |
| Medicare PECOS PAC ID | 0547257313 |
|---|---|
| Medicare Enrollment ID | O20040426001435 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801891940 | NPI | - | NPPES |
| 060288400 | Medicaid | FL |
| Provider Name | Ronny R Valenzuela |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1477648939 PECOS PAC ID: 2769472109 Enrollment ID: I20040518000520 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Randall D Cobb |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1750314605 PECOS PAC ID: 5890746358 Enrollment ID: I20050202000643 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Jeffrey J Edwards |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1376530360 PECOS PAC ID: 2769409820 Enrollment ID: I20051027000884 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Oscar Villaverde |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1801829726 PECOS PAC ID: 3870516826 Enrollment ID: I20060117000321 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Frank Willy Lehninger |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1154362556 PECOS PAC ID: 8729083464 Enrollment ID: I20061002000202 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Michele Weintraub |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1679514129 PECOS PAC ID: 5991690554 Enrollment ID: I20071129000556 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Laurie J Johnson |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1952594848 PECOS PAC ID: 7517027303 Enrollment ID: I20081124000735 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Jean Rony Rony Jean Mary |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1346317088 PECOS PAC ID: 5193815488 Enrollment ID: I20090107000623 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Haleh Tabrah |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1083640353 PECOS PAC ID: 9133272750 Enrollment ID: I20090729000836 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Amy E Simko |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1407094865 PECOS PAC ID: 1254477466 Enrollment ID: I20091001000234 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Edwin A Gomez |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1780775098 PECOS PAC ID: 4880735406 Enrollment ID: I20100105000354 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Robert Antoine |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1245249218 PECOS PAC ID: 9133189871 Enrollment ID: I20100113000519 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Paul G Baldizzi |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1982633350 PECOS PAC ID: 9234272725 Enrollment ID: I20100205000408 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Denise A Dutchak Parmenter |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1518024348 PECOS PAC ID: 8820054679 Enrollment ID: I20101005000369 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Evelio H Sosa |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1114055761 PECOS PAC ID: 3971404906 Enrollment ID: I20110307001001 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Scott Haltzman |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1922025766 PECOS PAC ID: 0042221046 Enrollment ID: I20130114000218 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Maribel Rivera-mulero |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1144427931 PECOS PAC ID: 0547352924 Enrollment ID: I20130130000283 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Ivette Cardelli |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1538405857 PECOS PAC ID: 0345474532 Enrollment ID: I20131001000110 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | C. Renee Washington-hyde |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1568533438 PECOS PAC ID: 1658458583 Enrollment ID: I20140312001533 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Ernesto Matos-gonzalez |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1578514865 PECOS PAC ID: 5294953329 Enrollment ID: I20140902001343 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Emily V Williams |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1780813287 PECOS PAC ID: 0446471536 Enrollment ID: I20141014000761 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Jean Evins Remy |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1902201874 PECOS PAC ID: 7315260502 Enrollment ID: I20150727001601 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Karen Buckner |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1871698654 PECOS PAC ID: 2668789835 Enrollment ID: I20150921001697 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Erin Kuhn |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1730430299 PECOS PAC ID: 4880901099 Enrollment ID: I20150921003013 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Frederick Stuart |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1184722985 PECOS PAC ID: 3577870781 Enrollment ID: I20150921003120 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Angela M Lopez |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1518233113 PECOS PAC ID: 6608183660 Enrollment ID: I20150923002810 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Mary K Soucek |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1881954584 PECOS PAC ID: 3779892906 Enrollment ID: I20151028002950 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Phara Lafortune-morame |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1225310253 PECOS PAC ID: 6901113059 Enrollment ID: I20151112000777 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Timothy J Macgeorge |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1275907875 PECOS PAC ID: 1850694183 Enrollment ID: I20160120002686 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Kelly M Chatterton |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1821392655 PECOS PAC ID: 1153582499 Enrollment ID: I20160411000206 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Maria Elena Zerpa-stolk |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1497847529 PECOS PAC ID: 9931181914 Enrollment ID: I20160427002106 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Brandon Madia |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1487093183 PECOS PAC ID: 2860785557 Enrollment ID: I20160718001520 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Marta Pieczalska |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1568417905 PECOS PAC ID: 2961415237 Enrollment ID: I20161227000427 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Jason Walsh |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1043670763 PECOS PAC ID: 9931493905 Enrollment ID: I20170207002965 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Peter Lewis |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1396286464 PECOS PAC ID: 3870870090 Enrollment ID: I20170425002964 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Gravil Joseph |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1164960720 PECOS PAC ID: 3870860398 Enrollment ID: I20170603000156 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Marcela Alvarez-lazo |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1477095305 PECOS PAC ID: 4183992779 Enrollment ID: I20170623000603 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Cynthia Gallo |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1013444124 PECOS PAC ID: 5395014252 Enrollment ID: I20170707003063 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | America Gomez |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1053822791 PECOS PAC ID: 9830459544 Enrollment ID: I20180126002629 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Ariella Vanhara |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1467959825 PECOS PAC ID: 1951666775 Enrollment ID: I20180529001457 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Rosa Elvira Smith |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1912302829 PECOS PAC ID: 4486972270 Enrollment ID: I20180718003704 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Jennifer Simms |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1821587676 PECOS PAC ID: 3779831722 Enrollment ID: I20180807003172 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Max Audran Belot |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1912449695 PECOS PAC ID: 5193074516 Enrollment ID: I20180817003037 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Natalia Saunders-roberts |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1063858249 PECOS PAC ID: 5092069393 Enrollment ID: I20181126000587 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Alfride Prevost-ricardo |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1962697961 PECOS PAC ID: 3870729403 Enrollment ID: I20190116000105 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Maurice Jeter |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1558543447 PECOS PAC ID: 8729151758 Enrollment ID: I20190220001839 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Catrina Lowance |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1326602632 PECOS PAC ID: 9234471855 Enrollment ID: I20190501001944 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Kathleen Nealon |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1972160679 PECOS PAC ID: 5294068094 Enrollment ID: I20190611000792 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Karel Rodriguez Milian |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1366804072 PECOS PAC ID: 2567756711 Enrollment ID: I20190729002216 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Lois M Harriman |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1558532952 PECOS PAC ID: 9537124938 Enrollment ID: I20190906000205 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Jason Fredrick Wagner |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1720536691 PECOS PAC ID: 2668806159 Enrollment ID: I20191216001077 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Septimio Julio Gonzalez Savournin |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1053962589 PECOS PAC ID: 9234565409 Enrollment ID: I20200206001307 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Tania Guerrier Castor |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1134762917 PECOS PAC ID: 9638507379 Enrollment ID: I20200312000527 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Claire Nancie Lubin |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1831711035 PECOS PAC ID: 5496171159 Enrollment ID: I20200812003131 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Miguel Molina Reynoso |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1689283384 PECOS PAC ID: 6800925025 Enrollment ID: I20200902000180 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Jada Stone Anastasia |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1790383073 PECOS PAC ID: 2163842444 Enrollment ID: I20201027000922 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Judi Mumm |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1518505346 PECOS PAC ID: 5799195822 Enrollment ID: I20201102000340 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Kara R Hardesty |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1841733912 PECOS PAC ID: 2769893155 Enrollment ID: I20201116000364 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Julienne Anna-carmelle Calixte |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1831795897 PECOS PAC ID: 9436561420 Enrollment ID: I20201216000928 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Alexandre Pigeon |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1780270157 PECOS PAC ID: 1052725819 Enrollment ID: I20210208000484 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Sonia Redio Rondon |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1659763779 PECOS PAC ID: 6901103522 Enrollment ID: I20210525000761 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | James Patrick Carey |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1487799540 PECOS PAC ID: 2163600131 Enrollment ID: I20210826002405 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Jennifer Scalia |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1881359768 PECOS PAC ID: 5092104059 Enrollment ID: I20211111002849 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Maxim Chasanov |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1124028584 PECOS PAC ID: 9234199233 Enrollment ID: I20211216002422 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Laura Hewett |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1093473381 PECOS PAC ID: 3375934433 Enrollment ID: I20211228000044 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Emlyne St Helen |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1053785980 PECOS PAC ID: 4587964051 Enrollment ID: I20220124001702 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Elizabeth Barley |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1568934743 PECOS PAC ID: 0345633590 Enrollment ID: I20220210001054 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Tatum Karos |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1811537632 PECOS PAC ID: 9739516212 Enrollment ID: I20220222000155 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Michelle Dion |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1982338588 PECOS PAC ID: 9234511429 Enrollment ID: I20220804002033 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Laura Desire |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1982330841 PECOS PAC ID: 9638555808 Enrollment ID: I20220927000167 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Richard Walsh |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1801510581 PECOS PAC ID: 3678949831 Enrollment ID: I20221013001793 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Erica Lapooh |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1104536085 PECOS PAC ID: 1355712985 Enrollment ID: I20230119000000 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Holly Orlasky |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1407300288 PECOS PAC ID: 1052777208 Enrollment ID: I20230515001439 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Mary Gibbons |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1386062644 PECOS PAC ID: 3375998222 Enrollment ID: I20231012000786 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Kendel Cooper |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1780318113 PECOS PAC ID: 8527416817 Enrollment ID: I20231127003389 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Holly Drouin |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1023795135 PECOS PAC ID: 6709234099 Enrollment ID: I20231127003437 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Ashley Swan |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1568963734 PECOS PAC ID: 7214385509 Enrollment ID: I20231128000050 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Britten Grayden |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1689381337 PECOS PAC ID: 3274981576 Enrollment ID: I20231128000253 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Margaret Baldwin |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1316014863 PECOS PAC ID: 6406204742 Enrollment ID: I20231128001782 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Emily Korolevich |
|---|---|
| Provider Type | Practitioner - Marriage And Family Therapist |
| Provider Identifiers | NPI Number: 1720708423 PECOS PAC ID: 1153779335 Enrollment ID: I20231129000044 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Alexander Conrad |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1952759342 PECOS PAC ID: 1456709583 Enrollment ID: I20231129002432 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Stephanie Rimes |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1780293324 PECOS PAC ID: 5496103566 Enrollment ID: I20231130000035 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Lauren Golia |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1891167920 PECOS PAC ID: 8325496433 Enrollment ID: I20231130001186 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Kathy Ann Jeffcoat |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1952569139 PECOS PAC ID: 3678921624 Enrollment ID: I20231130003525 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Nancy T Dauphinais |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1457669137 PECOS PAC ID: 5890143861 Enrollment ID: I20231201000122 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Abigail Pitts |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1467907261 PECOS PAC ID: 0345699039 Enrollment ID: I20231206002369 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Frances Crowley |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1376684654 PECOS PAC ID: 6507215951 Enrollment ID: I20231211000593 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Michele Santora |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1700362852 PECOS PAC ID: 6800245291 Enrollment ID: I20231211002004 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Laura E Birnie |
|---|---|
| Provider Type | Practitioner - Marriage And Family Therapist |
| Provider Identifiers | NPI Number: 1679758494 PECOS PAC ID: 9234589144 Enrollment ID: I20231219000518 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Zachary Thomas Dempsey |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1114517463 PECOS PAC ID: 8325499387 Enrollment ID: I20240104000689 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Barbara Jean Lanz |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1982605861 PECOS PAC ID: 9830144013 Enrollment ID: I20240108004773 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Mary Rand |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1457824377 PECOS PAC ID: 8022469592 Enrollment ID: I20240109002606 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
| Provider Name | Colette Thome |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1780332148 PECOS PAC ID: 5395197800 Enrollment ID: I20240120000361 |
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
News Archive
In the wake of divorce, illness, violence and other problems that can unsettle homes, countless young children are liable to experience temporary separations from one or both parents before packing their knapsack for kindergarten. Published in the May/June issue of Ambulatory Pediatrics, a new, community-wide study from Rochester, New York, warns that such kids are at increased risk for learning difficulties and that these separations are good predictors of which children may require special educational interventions to succeed.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, have identified how a specific stretch of DNA controls far-off genes to influence the formation of the face.
› Verified 8 days ago
Fresh Start Private Florida Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1415 Panther Ln, Naples, FL 34109 Phone: 239-591-6240 | |
Mindful Solutions Therapy, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4532 Tamiami Trl E Ste 302, Naples, FL 34112 Phone: 239-307-8038 | |
Psychotherapy Sw Fl Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 810 Anchor Rode Dr, Naples, FL 34103 Phone: 239-247-4231 | |
Little World Aba Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 708 Goodlette-frank Rd N Ste 326, Naples, FL 34102 Phone: 239-200-2405 | |
Dnt Institute Incorporated Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1750 Sw Health Pkwy, Naples, FL 34109 Phone: 239-566-7717 | |
Nami Of Collier County Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5020 Tamiami Trl N, Suite 110, Naples, FL 34103 Phone: 239-434-6726 | |
Behavioral Tender Care Corp Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 300 5th Ave S Ste 203d, Naples, FL 34102 Phone: 786-734-0684 |